HPV
The assay detects HPV 16 and HPV 18 DNA within 45 minutes and is intended to be used in low-resource settings.
Roche HPV Test Awarded World Health Organization Prequalification
Prequalified status enables Roche to provide the Cobas HPV test to more low- and middle-income countries.
Naveris, Mayo Clinic Begin Trial of Circulating Tumor DNA Test in Head and Neck Cancer
Researchers hope to establish the ability of Naveris' NavDx test to guide treatment intensity for patients with HPV-driven head and neck cancer.
Roche Diagnostics to Distribute ABL Diagnostics Tests in South Africa
Roche will distribute ABL's assays to microbiology labs testing for infectious diseases including HIV, tuberculosis, and cytomegalovirus.
AACC Issues New Cervical Cancer Detection Guidance
The new guidance includes an ideal lab report template and synthesizes guidelines previously issued by three other organizations.
Oct 28, 2021
Oct 12, 2021
Genematrix HPV Detection Test Nabs CE Mark
Oct 6, 2021
Feb 12, 2021
Oct 22, 2020